HUM
LONGCONGRESS BUYHUMANA INC
Research: Finviz ↗·Perplexity ↗
🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.
News Summary
NegativeHumana reported Q2 earnings beats with medical costs tracking expectations, but significantly cut full-year 2026 GAAP EPS guidance to $6.52 (from $8.36) due to a severe 'star ratings cliff' creating a $3.5B revenue headwind—membership in 4+ star plans collapsed from 94% to 45% due to stricter federal scoring. While CMS approved a strong 2.48% 2027 MA rate increase and the company won new Medicaid contracts, the near-term profitability headwinds, failed star ratings appeal, and planned MA exits affecting 600k members represent substantial near-term challenges.
Red flags
- •GAAP EPS guidance slashed 22% to $6.52 from initial $8.36 full-year outlook
- •Star ratings cliff: 94% of members in 4+ star plans (2024) fell to ~45% (2026), creating $3.5B net revenue headwind
- •CMS appeal for star ratings improvement denied in April 2026
- •Planned exits of approximately 600k members from Medicare Advantage plans with low star ratings
- •2026 Adjusted EPS guidance expects year-over-year decline vs. 2025
- •Analyst disappointment with maintained (not raised) 2026 guidance despite Q2 beat, contrasting with peer performance
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Glenview Capital | Larry Robbins | 335K | +335K | $58M | 1.6% | — | NEW |
| Duquesne Family Office | Stanley Druckenmiller | 138K | +138K | $24M | 0.8% | — | NEW |
| Soros Fund Management | Soros Family Office | 68K | +17K | $12M | 0.2% | +34% | Existing |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where HUM ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #19 of this fund's book
- 16APPLIED MATLS INC$67M
- 17ONTO INNOVATION INC$61M
- 18DICKS SPORTING GOODS INC$59M
- 19HUMANA INC$58M
- 20BUTTERFLY NETWORK INC$58M
- 21ELEMENT SOLUTIONS INC$56M
- 22UNITED AIRLS HLDGS INC$46M
position #26 of this fund's book
- 23Lattice Semiconductor Corp$30M
- 24Sandisk Corp$24M
- 25United Airls Hldgs Inc$24M
- 26Humana Inc$24M
- 27Wabtec$24M
- 28Twilio Inc$23M
- 29Jabil Inc$22M
Values are quarter-end position sizes. Shown only for funds where HUM ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Congressional Trading
| Member | Chamber | State | Type | Amount Range | Transaction Date | Filed | Src |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | senate | — | BUY | $1,001 - $15,000 | 2026-03-27 | 2026-07-21 | ↗ |
Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.